COPDに関連したPH/CCPのバイオマーカー:循環分子と細胞内マーカー
Juan Wang1, Yankun Zhang1, Huimin Liu1
1Department of Respiratory and Critical Care, Tianjin Medical University General Hospital, Tianjin, 300052, People's Republic of China.
International journal of chronic obstructive pulmonary disease
|August 21, 2025
まとめ
NT-proBNPや成長因子のようなバイオマーカーは,COPD患者の肺高血圧の診断に役立ちます. フォークヘッドボックスM1 (FOXM1) は,この状態の将来のスクリーニングツールとして有望です.
科学分野:
- 肺医学
- 血管生物学
- 分子 機構
背景:
- 慢性閉塞性肺疾患 (COPD) は進行する肺疾患である.
- COPDは肺高血圧 (PH) と慢性肺動脈高血圧 (CCP) に繋がり,罹病率と死亡率を著しく増加させます.
- 炎症メディエーターと成長因子によって誘発される血管の改造は,COPDに関連するPHの重要なメカニズムです.
研究 の 目的:
- COPDに関連するPHにおける血管再構成の分子メカニズムを調査する.
- 炎症媒介体,成長因子,およびPHとCCPのCOPDの診断マーカーとしてFOXM1を評価する.
主な方法:
- NT-proBNP,炎症媒介体,成長因子の血液採取による循環バイオマーカーの評価.
- 組織または濃縮細胞検出による細胞内分子マーカーFOXM1の評価
主要な成果:
- 循環するバイオマーカーは,非侵襲的,便利で,敏感で,特定の病気のスクリーニング方法を提供します.
- FOXM1は組織病理学的マーカーであり,液体生検の潜在的な標的である.
結論:
- NT-proBNP,炎症媒介体,成長因子などのバイオマーカーは,COPD患者のPHの早期スクリーニングと診断に価値があります.
- FOXM1は将来のスクリーニング戦略にとって有望な道を示し,患者のアウトカムと生活の質を改善する可能性があります.
関連する概念動画
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
213
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
213
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
01:20COPD: Pathogenesis and Clinical Features
517
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
517